Improving Genetic Testing Uptake in Prostate Cancer: Outcomes From a Multidisciplinary Clinic Evaluation [0.03%]
改善前列腺癌遗传咨询和检测的多学科联合门诊模式探索
Laura S Graham,Aditya Mantha,Chiagozie Paul-Onyia et al.
Laura S Graham et al.
Purpose: The National Comprehensive Cancer Network recommends germline genetic testing for patients with prostate cancer and high-risk features or a suggestive family history. In 2024, the University of Colorado Urologica...
Safety of Telemedicine Follow-Up Visits in Children With Cancer Undergoing Intensive Chemotherapy: Results From the Randomized KULT-SH Trial [0.03%]
远程医疗随访在重症化疗儿童癌症患者中的安全性：来自KULT-SH随机临床试验的结果
Denis M Schewe,Annika Rademacher,Patricia Kattner et al.
Denis M Schewe et al.
Purpose: Centralization of pediatric oncology care has increased the need for telemedicine. Evidence on its safety in highly vulnerable patients such as children undergoing intensive chemotherapy remains limited. ...
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma [0.03%]
社会经济差异与复发/难治多发性骨髓瘤患者生命质量之间的关系
Francesco Sparano,Gianluca Gaidano,Pasquale Niscola et al.
Francesco Sparano et al.
Purpose: Owing to prolonged treatment exposure, patients with relapsed/refractory multiple myeloma (RRMM), particularly those with low socioeconomic status (SES), may be especially vulnerable to financial toxicity (FT), w...
Responding to Medical Aid in Dying Requests: Practical Guidance for Oncologists as Legislation Expands [0.03%]
医学辅助死亡请求的应对：随着立法范围的扩大，肿瘤科医师的实际指导方针
Lindsey Ulin,Alexis Drutchas
Lindsey Ulin
Evaluating Disparities in Pediatric Cancer Genomic Testing and Sequencing Results at the University of California, San Francisco Using the National Childhood Cancer Registry [0.03%]
基于全国儿童癌症登记评估加利福尼亚大学旧金山分校儿科癌症基因组检测和测序结果的差异性
Meera Sangaramoorthy,Anushka Walia,Michelle Turski et al.
Meera Sangaramoorthy et al.
Purpose: The increasing role of genomic testing in pediatric cancer care decisions may contribute to outcome disparities. We evaluated drivers of genomic testing in the National Childhood Cancer Registry (NCCR) at the Uni...
Comparing the Rates of Hypersensitivity Reactions During First-Dose Taxane Infusions: Fixed-Rate Versus Stepwise Titration [0.03%]
紫杉醇首次输注时恒速给药和逐步加速给药的过敏反应发生率比较
Joan W Hong,Treasure Bright,Calvin Tucker et al.
Joan W Hong et al.
Purpose: Taxanes are associated with a higher incidence of immediate hypersensitivity reactions (HSRs) compared with other classes of chemotherapeutic agents, even with premedication. This study evaluates whether a titrat...
Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024 [0.03%]
2017年至2024年美国商业健康计划中肿瘤治疗利用管理趋势：2017-2024
Julia A Rucker,Molly T Beinfeld,Daniel Enright et al.
Julia A Rucker et al.
Purpose: Historically, commercial health plans have applied utilization management (UM) less frequently to oncology treatments than to drugs in other therapeutic areas although this may be changing. We evaluated trends in...
Giuseppe Maiocco,Vinicius Ernani,Michael P Gustafson et al.
Giuseppe Maiocco et al.
Adoptive cellular immunotherapy (ACT) has revolutionized hematologic malignancies, yet translation to solid tumors has historically been limited. This landscape shifted significantly in 2024 with US Food and Drug Administration approvals of...
Payer-Negotiated Prices in the Diagnosis and Management of Cutaneous Melanoma in 2025 [0.03%]
2025年皮肤黑色素瘤诊断和管理中的支付方谈判价格
Michael Y Bian,George Nassief,Victoria Ruesch et al.
Michael Y Bian et al.
Purpose: The 2021 Federal Hospital Price Transparency Final Rule requires hospitals to publicly disclose payer-negotiated prices for services. Despite rising cutaneous melanoma incidence and strong association with geogra...
Challenging the Dynamite Approach of Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer [0.03%]
挑战局部晚期直肠癌动态治疗的新辅助治疗总剂量法
Mirthe Ubink,Henk M W Verheul,Cornelis Verhoef et al.
Mirthe Ubink et al.